FGF-23 Hormone Linked to Risk for End-Stage Renal Disease - Medscape PDF Print
Medscape
June 16, 2011 — Fibroblast growth factor 23 (FGF-23), a hormone that regulates phosphorus metabolism, independently predicts the risk for end-stage renal disease (ESRD) in patients with relatively mild chronic kidney disease (CKD) and the risk for

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.